Nội dung chính của bài viết
Coronary heart disease in young patients always poses great challenges for every healthcare system with differences in clinical manifestations, etiology, epidemiology, angiographic characteristics and prognosis. The objective of this study was to describe a case of ST-elevation myocardial infarction complicated by cardiac arrest in a young patient with familial dyslipidemia. A 30-year-old male visited our hospital with typical angina. During the examination, he suﬀered a sudden loss of consciousness, the monitor showed ventricular fibrillation. After successful resuscitation of cardiac arrest, electrocardiography showed apparent ST-elevation from V2 to V6 leads consistent with the diagnosis of anterolateral infarction. Emergency coronary angiogram showed severe three-vessel lesions including complete occlusion of the LAD artery and 80 - 90% stenosis of the other two coronary branches. Our patient’s coronary arteries were revascularized using drug-eluting stents in LAD artery and subsequently RCA artery, stem cell therapy was applied during the interventional process. Routine laboratory test results showed dyslipidemia and his family records suggested familiar (hereditary) dyslipidemia which affected his mother and sister. 1-month follow-up echocardiography showed a drastic improvement of LVEF by roughly 15%. The combination of revascularization, stem cell therapy, and lipid-lowering therapy has shown a good therapeutic effect.
Chi tiết bài viết
STEMI in young patients, familial dyslipidemia
Tài liệu tham khảo
2. Doughty M, Mehta R, Bruckman D, Das S, Karavite D, Tsai T, et al. Acute myocardial infarction in the young - The University of Michigan experience. Am Heart J. 2002 Jan;143(1):56-62.
3. Zimmerman FH, Cameron A, Fisher LD, Grace NJJotACoC. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol. 1995 Sep;26(3):654-61.
4. Pineda J, Marín F, Roldán V, Valencia J, Marco P, Sogorb FJIjoc. Premature myocardial infarction: clinical profile and angiographic findings. Cardiol. 2008 May 7;126(1):127-9.
5. Gleerup H, Dahm C, Thim T, Jensen SE, Jensen LO, Kristensen SD, et al. Smoking is the dominating modifiable risk factor in younger patients with STEMI. European Heart Journal. Volume 39. Issue suppl_1. August 2018. ehy564.P792.
6. Sinha SK, Krishna V, Thakur R, Kumar A, Mishra V, Jha MJ, et al. Acute myocardial infarction in very young adults: A clinical
presentation, risk factors, hospital outcome index, and their angiographic characteristics in North India-AMIYA Study. ARYA Atheroscler.
2017 Mar;13(2):79-87. 7. Bolli R, Chugh AR, D’Amario D, Loughran JH, Stoddard MF, Ikram S, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011 Nov 26;378(9806):1847-57.
8. Zeljjkoo R, Alberico L.C., Gyu D.B et al. The Task Force for the management of dyslipidaemias of the European Society
of Cardiology (ESC) and the European Atherosclerosis Society (EAS). European Heart Journal. 2011;32:1769-1818.
9. Sheila A. F. Huaiun Zh., Carolyn D. et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2015 Sep 30;(9):CD006536.
10. Borja I., Stefan J., Stefan A. , et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. Volume 39. 2018;119-177.